Henley Ion Virus Defender Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Henley Ion Virus Defender's estimated annual revenue is currently $1.1M per year.(i)
  • Henley Ion Virus Defender's estimated revenue per employee is $155,000

Employee Data

  • Henley Ion Virus Defender has 7 Employees.(i)
  • Henley Ion Virus Defender grew their employee count by 17% last year.

Henley Ion Virus Defender's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4M2618%N/AN/A
#2
$1.4M90%N/AN/A
#3
$6.4M41-24%N/AN/A
#4
$2.5M16-6%N/AN/A
#5
$3.3M2140%N/AN/A
#6
$2.5M16-6%N/AN/A
#7
$0.8M50%N/AN/A
#8
$0.9M6-14%N/AN/A
#9
$6.4M418%N/AN/A
#10
$0.3M4100%N/AN/A
Add Company

What Is Henley Ion Virus Defender?

Invented by Harvard and Yale physician Dr. Julian Henley, The Henley Virus Defender is a science-based solution to the COVID-19 pandemic designed to help businesses keep their employees and customers safe. It’s patented electronic particle capture technology allows businesses to open, stay open, keep their workforce employed and safely serve their customers and communities. By combining proven technologies of ionization, electrostatic precipitation and safe ozone generation, The Henley Ion Virus Defender captures and safely neutralizes airborne particles. Comfort and fit are key features of The Henley Ion Virus Defender and is designed to be worn for extended periods of time. Conventional fiber filtration masks impede the flow of air, making it much more difficult to breathe. The Henley Ion Mask allows filtered air to flow freely to the user. It is reusable, rechargeable, lasts 8 hours, is water resistant and comes with a 12-month warranty. Educated at Harvard University and the Albert Einstein School of Medicine, Dr. Henley taught and practiced medicine at Yale School of Medicine for 22 years. He regularly works with the world’s pre-eminent medical experts and scientists, including faculty at Massachusetts Institute of Technology (MIT). Dr. Henley has been issued more than 34 patents over the course of his career, and he has partnered with global industrial leaders including Dow Corning in manufacturing groundbreaking medical technologies, including the artificial larynx.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A7-12%N/A
#2
$0.5M70%N/A
#3
$0.1M7-63%$102M
#4
$0.5M70%N/A
#5
$0.6M80%N/A